There's no appeal under the Bridge, but prescribers can resubmit the prior authorization form. The group explains who counts as Part D eligible instead.
Recap by typeshit. Full story at Center for Medicare Advocacy.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Feller urges people on GLP-1s to work with a registered dietitian and their provider so they keep getting enough nutrients while losing weight.
NBC10 Boston reports on fresh research showing weight loss drugs remain the biggest factor behind growing insurance spending in the state.
Loading…